PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice

79Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

Abstract

Hepatocyte death and proliferation contribute to hepatocellular carcinoma development after carcinogen exposure or chronic liver inflammation. However, the role and the molecular targets of hepatocyte death in relation to compensatory proliferation have not been fully characterized. In this study, we investigated the role of p53 up-regulated modulator of apoptosis (PUMA), a BH3-only protein important for both p53-dependent and -independent apoptosis, in a diethylnitrosamine (DEN)-induced liver carcinogenesis model. PUMA deficiency significantly decreased the multiplicity and size of liver tumors. DEN treatment induced p53-independent PUMA expression, PUMA-dependent hepatocyte death, and compensatory proliferation. Furthermore, inhibition or deletion of c-jun N-terminal kinase 1 (JNK1) abrogated PUMA induction, hepatocyte death, and compensatory proliferation. Conclusion: These results provide direct evidence that JNK1/PUMA-dependent apoptosis promotes chemical hepatocarcinogenesis through compensatory proliferation, and suggest apoptotic inducers as potential therapeutic targets in liver injury and cancer. © 2011 American Association for the Study of Liver Diseases.

Cite

CITATION STYLE

APA

Qiu, W., Wang, X., Leibowitz, B., Yang, W., Zhang, L., & Yu, J. (2011). PUMA-mediated apoptosis drives chemical hepatocarcinogenesis in mice. Hepatology, 54(4), 1249–1258. https://doi.org/10.1002/hep.24516

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free